DePuy Synthes Spine Systems Receive FDA Approval to Treat Scoliosis

DePuy Synthes Spine has received 510(k) clearance from the FDA for use of its EXPEDIUM, VIPER and VIPER2 Spine Systems on patients with adolescent idiopathic scoliosis.

Advertisement

The EXPEDIUM technology was first introduced in 2004. The VIPER and VIPER2 Spine Systems have been used in minimally invasive spine surgery for a wide range of pathologies since 2005 and 2008, respectively.

The new indication clears the way for the devices to be used in posterior non-cervical pedicle screw fixation in adolescent patients and for the company to provide training and education about its appropriate use.  

More Articles on Orthopedic Devices:

Spinal Elements Launches Ti-Bond

Exactech Announces 2Q Revenue of $55.2M, Up 7%

DJO Global 2Q Net Sales Reach $286M, a 2.9% Increase

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.